Amy E. Krambeck, MD, shares her thoughts on areas for ongoing research and development in the area of holmium laser enucleation of the prostate (HoLEP) for the treatment of benign prostatic hyperplasia.

 Amy E. Krambeck, MD, discusses patient selection for holmium laser enucleation of the prostate (HoLEP) for the treatment of benign prostatic hyperplasia. 

 Amy E. Krambeck, MD, reflects on Northwestern University performing 754 holmium laser enucleation of the prostate (HoLEP) procedures in 2024. 

​Endowed professorships represent one of the most prestigious honors a faculty member can receive, celebrating remarkable achievement and excellence. Among an elite group of 15 honorees from the Northwestern Feinberg School of Medicine, Dr. Amy Krambeck was named the Edmund Andrews Endowed Professor in Urology. These professorships are reserved for the institution’s most distinguished and accomplished physicians and scientists, carrying significant prestige and profound impact for the benefactor, the appointed professor, and the University as a whole.

Amy E. Krambeck, MD, highlights key takeaways from the BPH Update, which was presented at the 2023 American Urological Association Annual Meeting in Chicago, Illinois.

Nick Dean presented a study at the 2023 American Urological Association Annual Meeting, revealing that HoLEP's functional outcomes were comparable in patients, regardless of prior BPH procedures. 

Congratulations to Dr. Krambeck and the team for treating 1000 HoLEP patients at Northwestern Medicine

Amy E. Krambeck, MD, discusses her recent trial1comparing the efficacy of Trilogy and ShockPulse-SE lithotripters used in percutaneous nephrolithotomy (PCNL). Krambeck et al found that both devices are highly efficient and serve as notable advancements in stone-removal technologies, although fewer device malfunctions were reported when the Trilogy device was utilized.

Dr. Krambeck shares her first impressions on the Flex XC1 Single Use Ureteroscope, how it compares to her reusable scopes, and how she sees it playing a role in her practice.

​Dr. Amy Krambeck argues in favor of achieving stone-free status in all patients undergoing PCNL.

Amy Krambeck, MD, highlights 6 studies in BPH and urinary stones being presented at the 2022 American Urological Association Annual Meeting.

This year’s Women in Medicine conference featured a panel discussion about navigating and leading in medicine.

This year’s Women in Medicine conference featured a panel discussion about navigating and leading in medicine.

Amy E. Krambeck, MD, chief of the Division of Endourology and Stone Disease, and professor of Urology at Northwestern Medicine, is a world leader in holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia (BPH). In this video, Dr. Krambeck discusses the benefits of and surgical indications for HoLEP, and the impacts of upgraded MOSES laser technology.

Dr. Amy Krambeck, MD, a urologist at Northwestern Memorial Hospital and professor of urology at Northwestern University Feinberg School of Medicine discusses benign prostate hypertrophy (BPH) and the latest advancement in treatment options such as the new way to perform the HoLEP (Holmium Laser Enucleation of Prostate) procedure that is narcotics-free and allows 85% of patients to go home the same day.

In an interview with 16 News Now, Amy Krambeck, MD discusses the benefits of holmium laser enucleation of the prostate with an upgraded MOSES laser as a surgical treatment for lower urinary tract symptoms related to benign prostatic hyperplasia (BPH).

In an interview with Urology Times, Amy E. Krambeck, MD, discusses findings on the recent Urology Practice study, “The Economic Burden of Cystoscopy-Based Ureteral Stent Removal in the United States: An Analysis of Nearly 30,000 Patients.” She concluded that extraction strings may offer a safe and cost effective method for stent removals.

In a recent trial comparing the efficacy of Trilogy and ShockPulse-SE lithotripters used in percutaneous nephrolithotomy (PCNL), investigators found that both devices are highly efficient and serve as notable advancements in stone-removal technologies, although fewer device malfunctions were reported when the Trilogy device was utilized. “For harder, more aggressive stones, I'm more likely to use the Trilogy based on the results of the study. If I have a softer, easier stone, I prefer the lightness of the ShockPulse," said lead study investigator Amy E. Krambeck, MD.

​Dr. Krambeck was named one of the top rated Urologists in Indianapolis

Amy E. Krambeck, MD, discusses the findings of a recent 90-day trial of a single-use disposable ureteroscope

The benefits of holmium laser enucleation of the prostate with MOSES-enabled pulsed laser modulation justify its consideration as the gold standard surgical treatment for lower urinary tract symptoms related to benign prostatic hyperplasia, according to Amy E. Krambeck, MD.